![Addressing the yearly $53B problem for pharma companies using groundbreaking AI and ‘Patient- on-a-chip’ technology](https://industry.pharmafocusasia.com/slider/1719490827-addressing-the-yearly-01.png)
Ractigen Therapeutics a leader in small activating RNA therapies has received Rare Pediatric Disease Designation from the US Food and Drug Administration for its saRNA candidate RAG
IASO Biotechnology a company specializing in advanced cell therapy and antibody products has received approval from the National Medical Products Administration for its investigational new drug
Aforalls US subsidiary Milla Pharmaceuticals Inc has introduced its generic version of PrecedexDexmedetomidine Hydrochloride Injection in mcg per mL and mcg per mL formulated
Eisai Co Ltd and EcoNaviSta Inc have formed a strategic alliance to tackle dementia a significant challenge in Japans aging population Eisai a leader in dementia research and awareness and EcoNaviSta
Pfizer Inc has released positive topline results from the Phase AFFINE study which tested giroctocogene fitelparvovec a gene therapy for adults with moderately severe to severe hemophilia A
BeiGene Ltd a global oncology company has launched its flagship US facility at the Princeton West Innovation Campus in Hopewell NJ This advanced site features cuttingedge biologics
Macquarie University researchers have identified a gene therapy that could help treat the eye disease glaucoma with potential applications for other neurodegenerative conditions such as Alzheimers disease Glaucoma may result in irreversible blindness over to years if left untreated Like Alzheimers...
BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that dosing has recently begun in an integrated Phase I
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology cardiovascular and metabolic
ObvioHealth a global digital clinical trials company announces a new strategic investment by Guardant Health Inc a leading precision oncology company offering liquid
BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that the FDA has accepted the BLA for BAT a proposed
NanoViricides Inc a clinical stage global leader in broadspectrum antiviral nanomedicines today reminds the strong safety and effectiveness against coronaviruses demonstrated by its lead clinical drug candidate
Boston, MA, USA
jakarta barat, Indonesia
Jakarta Barat, Indonesia
Songdo Convensia, Incheon, South Korea
Songdo Convensia, Incheon, South Korea
Lisbon, Portugal
London, UK
Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University
Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University
Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University; Department of Entomology, University of California; UC Davis Comprehensive Cancer Center, University of California. Electronic address: [email protected]
Chief Executive Officer, Juniper Biologics
Department of Engineering Science, University of Oxford.
Department of Chemistry, University Institute of Sciences, Chandigarh University
Director
Clinical trials have very detailed and precise processes and the logistical elements of these processes are critical Recent revisions to the pharmaceutical industrys regulatory laws as well as improved patent laws in countries such as Japan China and India have led to the burgeoning clinical trials market in AsiaPROCESS WEIGHING AND RECORDING BY OBSERVATIONThis is the process flow for weighing the reference standard where the values are recorded by observation from the balance screen and written into a laboratory notebook by an analyst The subsequent calculations are performed using a handheld calculator with the res
Rassoul Dinarvand A A Elham Khodaverdi A Fatemeh Atyabi A Mohammad Erfan AA Department of Pharmaceutics Faculty of Pharmacy Tehran University of Medical Sciences Tehran IranA Pharmaceutical Sciences Research Centre Tehran University of Medical
AbstractHydrazine NH is a known genotoxic impurity that typically needs to be controlled down to low ppm level in pharmaceutical development Hydrazine however is a challenging molecule to analyze using conventional analytical techniques due to its physical and chemical properties eg lack of chromophore absence of any carbon atom low molecular weigh
The researchers from Tokyo University of Science have developed an automated device for cancer cell electrical property analysis allowing the simultaneous evaluation of many cells
Biomarkers are indicators of homeostasis disease states or pharmacological interventions An ideal biomarker must be bina present or absent quantifiable in tissues cells body fluids or in simple physiological parameters
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster